[go: up one dir, main page]

Abraham et al., 1987 - Google Patents

Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex

Abraham et al., 1987

Document ID
7115282154499118272
Author
Abraham K
Ieni J
Meyerson L
Publication year
Publication venue
Biochimica et Biophysica Acta (BBA)-General Subjects

External Links

Snippet

An endogenous modulator for the site labeled by [3 H] imipramine which is putatively coupled to the serotonin transporter in human platelets was isolated and purified from plasma. Procrdures included sequential chromatography on Cibacron blue-Sepharose 4B …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Similar Documents

Publication Publication Date Title
Abraham et al. Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex
Bizzini et al. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems
Karlsson Chemistry of protein toxins in snake venoms
Sanger The chemistry of insulin
Araujo et al. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes.
Siman et al. Regulation of glutamate receptor binding by the cytoskeletal protein fodrin
Kawamoto et al. Isolation, characterization, and localization of the spanning protein from skeletal muscle triads.
Michaelis Partial purification and characterization of a glutamate-binding membrane glycoprotein from rat brain
Hullin et al. Purification, radioimmuno assay, and distribution of human brain 14-3-2 protein (nervous-system specific enolase) in human tissues
US4649132A (en) Treatment of Factor VIII inhibitors
JPS61205219A (en) Biologically active human antihemophilic factor fragment andmanufacture
Jin et al. Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical
Palasuberniam et al. Snake venom proteomics of Samar cobra (Naja samarensis) from the Southern Philippines: Short alpha-neurotoxins as the dominant lethal component weakly cross-neutralized by the Philippine cobra antivenom
van der Rest et al. A comprehensive approach to the study of collagen primary structure based on high‐performance liquid chromatography
Mickelson et al. Steroid-protein interactions. Human corticosteroid-binding globulin: characterization of dimer and electrophoretic variants
Volkova et al. Low molecular weight components from black widow spider venom
Volpina et al. A fragment of the receptor for advanced glycation end products restores the spatial memory of animals in a model of Alzheimer’s disease
Hamscher et al. Identification of proxenin as a precursor of the peptide xenin with sequence homology to yeast and mammalian coat protein α
Rainbow et al. Distribution, survival and biological effects in mice of a behaviorally active, enzymatically stable peptide: pharmacokinetics of cyclo (Leu-Gly) and puromycin-induced amnesia
Friedmann et al. Thrombin attenuation is neuroprotective in the injured rat optic nerve
Han et al. Role of conserved peptide in taurine transporter inactivation modulated by protein kinase C.
Kubiak et al. Synthetic peptides VH (27-68) and VH (16-68) of the myeloma immunoglobulin M603 heavy chain and their association with the natural light chain to form an antigen binding site
Muszynska et al. Chemical modification of carboxypeptidase A crystals. Nitration of tyrosine-248
Bergstrand Localization of antigenic determinants on bovine encephalitogenic protein further studies with the macrophage migration inhibition assay in guinea-pigs
AU2002242273C1 (en) Compositions of multimeric profilin for diagnosis and treatment of allergies